Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

No association between Fas A/G polymorphism and therapeutic effects induced by methimazole treatment for Graves' disease in Northern Chinese.

Die Pharmazie - 1 Oct 2008

Li Ping, Li Qiang, Chen Lili, Sun Yuquian, Zhang Jinchao

Abstract excerpt

Fas gene, which is related to apoptosis, influences the clinical remission of Graves' disease (GD). This study was performed to determine whether the Fas gene promoter polymorphism at position-670 is associated with different efficacy in GD patients treated with methimazole (MMI). Serum levels of thyroid hormone, sFas and thyrotropic-stimulating hormone receptor antibodies (TRAb) were evaluated as therapeutic...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to China
Share to DNA
Share to fas Receptor

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Graves Disease

Share to Polymorphism, Restriction Fragment Length

Share to Reverse Transcriptase Polymerase Chain Reaction

Share to Thyroid Hormones

Share to Thyrotropin

Source

Identifiers

PMID: 18972838

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

No association between Fas A/G polymorphism and therapeutic effects induced by methimazole treatment for Graves' disease in Northern Chinese.PMID 18972838Read ↗

Tumor necrosis factor alpha (TNF-alpha) polymorphisms in Chinese patients with Graves' disease.Semantic proximity Read ↗

Association of TNF-α promoter polymorphism and Graves' disease: an updated systematic review and meta-analysis.Semantic proximity Read ↗

Involvement of genes encoding apoptosis regulatory factors (FAS, FASL, TRAIL, BCL2, TNFR1 and TNFR2) in the pathogenesis of autoimmune thyroid diseases.Semantic proximity Read ↗

TNFSF15 Polymorphisms are Associated with Graves' Disease and Graves' Ophthalmopathy in a Han Chinese Population.Semantic proximity Read ↗

Methylation levels of the TNFA gene are different between Graves' and Hashimoto's diseases and influenced by the TNFA polymorphism.Semantic proximity Read ↗

[Association of TNF-α gene polymorphisms with Graves disease susceptibility and early course thyroid stimulating hormone receptor antibody level in Chinese Han population in Anhui region].Semantic proximity Read ↗

Dual effect of a polymorphism in the macrophage migration inhibitory factor gene is associated with new-onset Graves disease in a Taiwanese Chinese population.Semantic proximity Read ↗

Correlations of TNF-α gene promoter polymorphisms with the risk of thymoma-associated myasthenia gravis in a northern Chinese Han population.Semantic proximity Read ↗

Association of tumour necrosis factor alpha (TNF-alpha) polymorphisms with Graves' disease: A meta-analysis.Semantic proximity Read ↗

Gene polymorphisms of pro-inflammatory cytokines may affect the risk of Graves' disease: a meta-analysis.Semantic proximity Read ↗

Correlation of HLA-DQ and TNF-α gene polymorphisms with ocular myasthenia gravis combined with thyroid-associated ophthalmopathy.Semantic proximity Read ↗

IL-18 gene polymorphism confers susceptibility to the development of anti-GAD65 antibody in Graves' disease.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.